Research Article

A Possible Mechanism: Vildagliptin Prevents Aortic Dysfunction through Paraoxonase and Angiopoietin-Like 3

Figure 1

Effect of vildagliptin on metabolic parameters in rats. (a) Body weight, (b) fasting blood glucose, (c) insulin, (d) homeostasis model assessment (HOMA-IR), (e) blood glucose in oral glucose tolerance test (OGTT), (f) area under the curve (AUC) in OGTT, (g) total cholesterol, (h) triglyceride, (i) high-density lipoprotein cholesterol (HDL-C), (j) low-density lipoprotein cholesterol (LDL-C), and (k) relaxation responses to Ach in aortic rings. Values are mean ± SD (), , , versus control group; , versus diabetic group. vil-low: low dose of vildagliptin; vil-high: high dose of vildagliptin.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)